Bert N van Geel

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence
    Carmen C van der Pol
    Department of Surgical Oncology, Erasmus Medical Centre Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Ann Surg Oncol 16:3414-21. 2009
  2. ncbi Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands
    Urology 70:143-7. 2007
  3. ncbi Partial mastectomy and m. latissimus dorsi reconstruction for radiation-induced fibrosis after breast-conserving cancer therapy
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
    World J Surg 35:568-72. 2011
  4. ncbi Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    World J Surg 35:63-9. 2011
  5. ncbi Chest wall resection for internal mammary lymph node metastases of breast cancer
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Breast 18:94-9. 2009
  6. ncbi [Long-term results of the multidisciplinary surgical treatment of non-small-cell bronchial carcinoma in the superior sulcus (Pancoast tumour): a retrospective study]
    A N van Geel
    Erasmus MC, Daniel den Hoed, Groene Hilledijk 301, 3075 EA Rotterdam
    Ned Tijdschr Geneeskd 151:1406-11. 2007
  7. ncbi Prophylactic mastectomy: the Rotterdam experience
    A N van Geel
    Erasmus Medical Center Daniel den Hoed, Rotterdam, The Netherlands
    Breast 12:357-61. 2003
  8. ncbi TNF dose reduction in isolated limb perfusion
    D J Grunhagen
    Department of Surgical Oncology, Erasmus MC Daniel den Hoed Cancer Center, P O Box 5201, 3008 AE, Rotterdam, The Netherlands
    Eur J Surg Oncol 31:1011-9. 2005
  9. ncbi Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement
    A Y de Kanter
    Department of Surgery, Erasmus University Medical Centre-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Eur J Surg Oncol 32:498-501. 2006
  10. ncbi Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Oncol 17:1578-85. 2006

Collaborators

Detail Information

Publications37

  1. ncbi Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence
    Carmen C van der Pol
    Department of Surgical Oncology, Erasmus Medical Centre Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Ann Surg Oncol 16:3414-21. 2009
    ..It remains a challenge to select patients that will benefit most from this treatment. The aim of this study was to define prognostic factors in patients who undergo CWR with curative intent...
  2. ncbi Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands
    Urology 70:143-7. 2007
    ..To analyze the clinical features, prognostic factors, and survival of male patients with primary mucosal melanoma on the glans penis, meatus, fossa navicularis, and distal urethra...
  3. ncbi Partial mastectomy and m. latissimus dorsi reconstruction for radiation-induced fibrosis after breast-conserving cancer therapy
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
    World J Surg 35:568-72. 2011
    ..Patients with severe complaints of radiation-induced fibrosis after breast-conserving therapy and not responding to conservative therapy, were treated by partial mastectomy and m. latissimus dorsi reconstruction...
  4. ncbi Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    World J Surg 35:63-9. 2011
    ..Information about treatment outcome and prognostic factors of adult sarcoma requiring chest wall resection (CWR) is limited...
  5. ncbi Chest wall resection for internal mammary lymph node metastases of breast cancer
    Albertus N van Geel
    Department of Surgical Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Breast 18:94-9. 2009
    ..008) are independent prognostic factors. Chest wall resection is a safe and effective treatment for isolated breast cancer recurrences in the IMC. Surgically treated patients have a fair survival and some of them are even cured...
  6. ncbi [Long-term results of the multidisciplinary surgical treatment of non-small-cell bronchial carcinoma in the superior sulcus (Pancoast tumour): a retrospective study]
    A N van Geel
    Erasmus MC, Daniel den Hoed, Groene Hilledijk 301, 3075 EA Rotterdam
    Ned Tijdschr Geneeskd 151:1406-11. 2007
    ....
  7. ncbi Prophylactic mastectomy: the Rotterdam experience
    A N van Geel
    Erasmus Medical Center Daniel den Hoed, Rotterdam, The Netherlands
    Breast 12:357-61. 2003
    ..The most striking result of PM is the decrease of anxiety of developing breast cancer and a negative impact on their sexual life. Therefore a time delay is necessary to allow women to fully address the issues involved in PM and IBR...
  8. ncbi TNF dose reduction in isolated limb perfusion
    D J Grunhagen
    Department of Surgical Oncology, Erasmus MC Daniel den Hoed Cancer Center, P O Box 5201, 3008 AE, Rotterdam, The Netherlands
    Eur J Surg Oncol 31:1011-9. 2005
    ..The optimal dose of TNF for this procedure is not well established. The aim of this study was to assess the efficacy and toxicity of TM-ILPs with reduced TNF dose...
  9. ncbi Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement
    A Y de Kanter
    Department of Surgery, Erasmus University Medical Centre-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Eur J Surg Oncol 32:498-501. 2006
    ..CONCLUSIONS: Extensive nodal involvement is an important cause of failure of the sentinel node biopsy. Pre-operative ultrasound examination of the axilla can avoid this in almost two thirds of these patients...
  10. ncbi Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Oncol 17:1578-85. 2006
    ..Therefore, our data suggest that patients with sub-micrometastases (<0.1 mm) in the SN may be judged as SN negative, as non-stage III, and are highly unlikely to benefit from CLND, which we no longer recommend...
  11. ncbi Sentinel node biopsy for clear cell sarcoma
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Center Daniel den Hoed Cancer Center, Groene Hilledijk 301, Kamer B3 16, 3075 EA, Rotterdam, The Netherlands
    Eur J Surg Oncol 32:996-9. 2006
    ..SN status seems to predict additional nodal involvement and recurrent disease as well as survival. The SN procedure might be a useful and accurate staging procedure in CCS patients, comparable to the situation in melanoma...
  12. ncbi Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
    J P Deroose
    Division of Surgical Oncology, Erasmus MC Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Br J Surg 98:1573-80. 2011
    ..This article reports the long-term results of adding TNF-α to standard melphalan-based ILP (TM-ILP) for treatment of melanoma in-transit metastases...
  13. ncbi TNF-based isolated limb perfusion in unresectable extremity desmoid tumours
    D J Grunhagen
    Department of Surgical Oncology, Erasmus MC, Daniel den Hoed Cancer Center, P O Box 5201, 3008 AE Rotterdam, The Netherlands
    Eur J Surg Oncol 31:912-6. 2005
    ..As isolated limb perfusion (ILP) with TNF and melphalan has proven to be extremely effective in the treatment of soft tissue sarcoma, we studied its potential in locally advanced extremity desmoid tumours...
  14. ncbi High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands
    Eur J Cancer 42:372-80. 2006
    ..The SN status is the most important predictive value for DFS and OS. In-transit metastasis rates correlated with SN-positivity, Breslow thickness and ulceration of the primary...
  15. ncbi Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy
    C Seynaeve
    Family Cancer Clinic, Department of Medical Oncology, Erasmus University Medical Centre Daniel den Hoed Cancer Centre, Groene Hilledijk, 301, 3075 EA Rotterdam, The Netherlands
    Eur J Cancer 40:1150-8. 2004
    ..These data suggest an indication for long-term follow up in HBC and should be taken into account when additional 'risk-reducing' surgery after primary BCT is eventually considered...
  16. ncbi Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs
    T E Lans
    Department of Surgical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, PO Box 5201, 3008 AE Rotterdam, The Netherlands
    Ann Surg Oncol 12:406-11. 2005
    ..Regional toxicity was limited and systemic toxicity minimal. CONCLUSIONS: TNF-based ILP can avoid amputations in most patients with recurrent extremity STS in a prior operated and irradiated field...
  17. ncbi Value of estrogenic recruitment before chemotherapy: first randomized trial in primary breast cancer
    M Bontenbal
    Departments of Medical Oncology, Statistics, Surgery, and Radiotherapy, Rotterdam Cancer Institute Daniel den Hoed Kliniek, University Hospital Rotterdam, Rotterdam, The Netherlands
    J Clin Oncol 18:734-42. 2000
    ..Therefore, the efficacy of estrogenic recruitment followed by chemotherapy was compared with that of chemotherapy alone in a randomized phase III study in women with lymph node-positive primary breast cancer...
  18. ncbi Forequarter amputation for malignancy
    J Rickelt
    Department of Surgical Oncology, Erasmus Medical Centre Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Br J Surg 96:792-8. 2009
    ..Forequarter amputation (FQA) is an important treatment for malignant disease of the shoulder girdle. The aim of this study was to elucidate its role in surgical oncology...
  19. ncbi Should internal mammary chain (IMC) sentinel node biopsy be performed? Outcome in 90 consecutive non-biopsied patients with a positive IMC scintigraphy
    M W J M Wouters
    Department of Surgical Oncology, Erasmus Medical Center Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Breast 17:152-8. 2008
    ..Although the status of the regional lymph nodes is an important determinant of prognosis in breast cancer, harvesting sentinel nodes (SN) detected in the internal mammary chain (IMC) is still controversial...
  20. ncbi Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Center Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands
    Eur J Surg Oncol 33:102-8. 2007
    ..In conclusion, TLND for stage III melanoma is accompanied with considerable short-term complications, and can achieve regional control and potential curation in approximately one in every four patients...
  21. ncbi The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy
    P J C Bresser
    Department of Medical Psychology and Psychotherapy, Erasmus MC, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur J Cancer 43:95-103. 2007
    ..More research is needed to further define the characteristics of the women who continue to have clinically relevant increased scores after surgery, in order to offer them additional counselling...
  22. ncbi Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha
    D J Grunhagen
    Department of Surgical Oncology, Erasmus University MC Daniel den Hoed Cancer Center, P O Box 5201, 3008 AE Rotterdam, The Netherlands
    Eur J Surg Oncol 32:371-80. 2006
    ..When multiple, large lesions exist, isolated limb perfusion (ILP) has established itself as an attractive treatment option with high response rates...
  23. ncbi 5-Year follow-up of sentinel node negative breast cancer patients
    A Y de Kanter
    Department of Surgical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Eur J Surg Oncol 32:282-6. 2006
    ..CONCLUSION: It can be concluded that the incidence of axillary recurrences after negative SN is much lower than expected. There is no added value of US and FNAC of the axilla in the routine follow-up of SN negative patients...
  24. ncbi Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial
    A M Eggermont
    Department of Surgical Oncology, University Hospital Rotterdam Daniel den Hoed Cancer Center, The Netherlands
    J Clin Oncol 14:2653-65. 1996
    ....
  25. ncbi Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial
    J Bonnema
    Department of Surgical Oncology, University Hospital Rotterdam Daniel den Hoed Cancer Center, Zuider Hospital Rotterdam, PO Box 5201, 3008 AE Rotterdam, Netherlands
    BMJ 316:1267-71. 1998
    ..To assess the medical and psychosocial effects of early hospital discharge after surgery for breast cancer on complication rate, patient satisfaction, and psychosocial outcomes...
  26. ncbi Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation
    C M E Contant
    Department of Surgical Oncology, University Hospital Rotterdam/Daniel den Hoed Cancer Centre, Zuiderziekenhuis Rotterdam, The Netherlands
    Eur J Surg Oncol 28:627-32. 2002
    ..PM can simultaneously be combined with PBO and IBR. IBR can facilitate the decision to undergo a PM. PM followed by IBR has an acceptable complication rate...
  27. ncbi Survival and prognostic factors in BRCA1-associated breast cancer
    C T M Brekelmans
    Department of Medical Oncology, Department of Surgical Oncology and Department of Clinical Genetics, Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Oncol 17:391-400. 2006
    ..Further, the prognostic impact of the classical tumour and treatment factors is unclear in BRCA1-associated BC...
  28. ncbi Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection
    A P T van der Ploeg
    Department of Surgical Oncology, Erasmus University Medical Center Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Ann Surg Oncol 18:3300-8. 2011
    ..The aim of this study is to evaluate the experience in CGD versus SGD patients in our center...
  29. ncbi Cancer of the breast with nipple involvement
    R S Menon
    Department of Pathology Dr Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Br J Cancer 59:81-4. 1989
    ..This factor will have to be taken into account in planning conservative therapeutic programmes...
  30. ncbi [Preventive surgical prcedures for inherited risk of breast cancer]
    M B E Menke-Pluymers
    Erasmus MC Daniel den Hoed Oncologisch Centrum, Postbus 5201, 3008 AE Rotterdam
    Ned Tijdschr Geneeskd 149:2663-7. 2005
    ..The complexity of the problem demands a multidisciplinary approach within the context of a family cancer clinic...
  31. ncbi [Oncoplastic surgery of the breast: a combination of oncological and plastic surgery]
    M B E Menke-Plugmers
    Erasmus MC Daniel den Hoed Oncologisch Centrum, afd Chirurgische Oncologie, Postbus 5201, 3008 AE Rotterdam
    Ned Tijdschr Geneeskd 151:1623-7. 2007
    ..Oncoplastic principles can easily be applied to basic breast-sparing surgery, but one can also choose to increase the possibilities of breast surgery by organising good cooperation between the oncological surgeon and the plastic surgeon...
  32. ncbi Extra-axial chordoma
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Center, Postbus 2040, 3000 CA, Rotterdam, The Netherlands
    J Bone Joint Surg Br 88:1232-4. 2006
    ..We report the case of a 56-year-old woman who developed an extra-axial chordoma of the right thoracic wall in close relationship with the tenth rib. The tumour was completely removed and the prognosis is excellent...
  33. ncbi Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery
    I J M Han-Geurts
    Department of Surgical Oncology, Erasmus Medical Centre/Daniel den Hoed Cancer Centre, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Eur J Surg Oncol 32:1217-21. 2006
    ..This casts doubt on the necessity of extensive surgery, especially in cases where an extensive surgical procedure will lead to great morbidity...
  34. ncbi Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable sSewart-Treves lymphangiosarcoma
    T E Lans
    Department of Surgical Oncology, Daniel den Hoed Cancer Centre, University Hospital Rotterdam, Rotterdam, The Netherlands
    Ann Surg Oncol 9:1004-9. 2002
    ..ILP with tumor necrosis factor (TNF) and melphalan is a safe and highly effective procedure that can achieve limb salvage in >or=80% of all patients with nonresectable extremity soft tissue sarcoma or melanoma...
  35. ncbi Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy
    Murly Bm Tan
    Department of Psychosocial Care, Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Hered Cancer Clin Pract 7:6. 2009
    ..This may help them arrive at an informed decision, to detect and manage psychological distress, and to plan psychological support services...
  36. ncbi Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study
    Iris van Oostrom
    Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands
    J Clin Oncol 21:3867-74. 2003
    ..To explore long-term psychosocial consequences of carrying a BRCA1/2 mutation and to identify possible risk factors for long-term psychological distress...
  37. ncbi A prospective study on silicone breast implants and the silicone-related symptom complex
    C M E Contant
    University Hospital Rotterdam/Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Clin Rheumatol 21:215-9. 2002
    ..Moreover there was no correlation between elevated SRSC expression and changes in the presence of ANA or changes in MRI of the SBI 1 year after IBR...